3Hassan K, Cowan F J, Jenkins HR. The incidence of childhood inflammatory bowel disease in wales[J]. Eur J Pediatr, 2000; 159:261-263.
4Griffiths AM, Nicholas D, Smith C, et al. Development of a quality of life index for pediatric inflammatory bowel disease: dealing with differences related to age and IBD type [ J ]. J Pediatr Gastroenterol Nutr, 1999;28:46-52.
5Vermeire S,Peeters M,Rutgeerts P. Diagnosic approach to IBD [J].Hepato-Gastroerol erol, 2000; 47: 44 - 48.
6Charron M, Rosori O, Kocoshis S A. et al. Pediatric inflammatory bowel disease:assessment with scintigraphy with Tc^99m white blood cells [ J ]. Radiology, 1999; 8: 507 - 514.
7Levine A, Weizman Z, Broide E,et al. A comparison of budesonide and prednisone for the treatment of active pediatric Crohn disease [J ]. J Pediatr Gastroenterol Nutr, 2003,36: 245 - 252.
8Stephens MC, Shepanski MA, Mamula P, et al. Safety and steroid - sparing experience using infliximab for Crohn disease at a pediatric inflammatory bowel disease center[J ]. Am J Gastroenterol,2003,98:104- 111.
9Cezard JP, Nouaili N, Talbotec C, et al. A prospective study of efficacy and tolerance of a chimeric antibody to tumor necrosis factors (remicade) in severe pediatric crohn disease[J]. J Pediatr Gastroenterol Nutr,2003,36: 632 - 636.
10Kugathasan S, Judd RH, Hoffrnan RG, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population - based study [J]. J Pediatr,2003,143: 525 - 531.
